Veeva Systems (NYSE:VEEV – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday.
Other equities research analysts have also issued research reports about the company. Wells Fargo & Company boosted their price objective on Veeva Systems from $275.00 to $285.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Citigroup upped their price objective on Veeva Systems from $281.00 to $307.00 and gave the company a “buy” rating in a research note on Monday, December 9th. Bank of America lifted their target price on shares of Veeva Systems from $280.00 to $290.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. Stephens assumed coverage on shares of Veeva Systems in a research report on Friday, December 20th. They issued an “overweight” rating and a $280.00 price target for the company. Finally, Robert W. Baird lifted their price target on shares of Veeva Systems from $275.00 to $283.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and seventeen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $253.96.
Check Out Our Latest Analysis on Veeva Systems
Veeva Systems Price Performance
Insider Transactions at Veeva Systems
In other Veeva Systems news, SVP Jonathan Faddis sold 1,694 shares of the company’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $230.30, for a total transaction of $390,128.20. Following the sale, the senior vice president now directly owns 8,061 shares of the company’s stock, valued at $1,856,448.30. This represents a 17.37 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Thomas D. Schwenger sold 1,126 shares of Veeva Systems stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $240.01, for a total transaction of $270,251.26. Following the completion of the transaction, the insider now owns 27,013 shares of the company’s stock, valued at $6,483,390.13. The trade was a 4.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 10.50% of the company’s stock.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of VEEV. Dimensional Fund Advisors LP raised its position in shares of Veeva Systems by 26.2% in the second quarter. Dimensional Fund Advisors LP now owns 378,380 shares of the technology company’s stock worth $69,259,000 after buying an additional 78,654 shares in the last quarter. Amalgamated Bank lifted its holdings in shares of Veeva Systems by 2.1% during the 2nd quarter. Amalgamated Bank now owns 9,968 shares of the technology company’s stock worth $1,824,000 after acquiring an additional 201 shares during the last quarter. Pacer Advisors Inc. grew its position in Veeva Systems by 31.4% in the second quarter. Pacer Advisors Inc. now owns 5,688 shares of the technology company’s stock worth $1,041,000 after acquiring an additional 1,359 shares in the last quarter. Bank of Montreal Can increased its stake in Veeva Systems by 272.7% in the second quarter. Bank of Montreal Can now owns 152,697 shares of the technology company’s stock valued at $28,463,000 after acquiring an additional 111,724 shares during the last quarter. Finally, Marshall Wace LLP purchased a new stake in Veeva Systems during the second quarter valued at about $21,769,000. 88.20% of the stock is currently owned by hedge funds and other institutional investors.
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Read More
- Five stocks we like better than Veeva Systems
- How to Calculate Options Profits
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- How to Effectively Use the MarketBeat Ratings Screener
- 3 Buy-and-Hold Stocks for Long-Term Growth
- How to Calculate Return on Investment (ROI)
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.